A Phase II Study of Gemcitabine and Capecitabine in Advanced Cholangiocarcinoma and Carcinoma of the Gallbladder: A Single-Institution Prospective Study

[1]  P. Philip,et al.  Phase II study of erlotinib in patients with advanced biliary cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[3]  G. Pond,et al.  Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Myron N. Chang,et al.  Samples of exact k-stage group sequential designs for Phase II and Pilot studies. , 2004, Controlled clinical trials.

[5]  E. Papalambros,et al.  Weekly Gemcitabine for the Treatment of Biliary Tract and Gallbladder Cancer , 2004, Investigational New Drugs.

[6]  Z. Aziz,et al.  Prospective Evaluation of Efficacy and Toxicity of 5‐FU and Folinic Acid (Mayo Clinic Regimen) in Patients With Advanced Cancer of the Gallbladder , 2003, American Journal of Clinical Oncology.

[7]  D. Fairclough.  Design and analysis of quality of life studies in clinical trials , 2002, Quality of Life Research.

[8]  R. Schilsky,et al.  Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  G. Colucci,et al.  Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  L. Orlandi,et al.  A phase II study of gemcitabine in gallbladder carcinoma. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  T. Patel.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[12]  W. Scheithauer,et al.  Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  J. Seo,et al.  Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas. , 2000, American Journal of Clinical Oncology.

[14]  G. Rosner,et al.  Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Ducreux,et al.  A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma. , 2000, European journal of cancer.

[16]  G. Gores,et al.  Biliary tract cancers. , 1999, The New England journal of medicine.

[17]  H. Friess,et al.  Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. , 1999, European journal of cancer.

[18]  M. Pruckmayer,et al.  The role of chemotherapy and radiation in the management of biliary cancer: a review of the literature. , 1998, European journal of cancer.

[19]  D. V. Von Hoff,et al.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  G. Nikou,et al.  Chemotherapy of biliary tract cancer with mitomycin-C and 5-fluorouracil biologically modulated by folinic acid. A phase II study. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  J. Vauthey,et al.  Recent Advances in the Management of Cholangiocarcinomas , 1994, Seminars in liver disease.

[22]  R. Audisio,et al.  Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  P. Schein,et al.  5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  C. Moertel,et al.  Eastern cooperative oncology group experience with chemotherapy for inoperable gallbladder and bile duct cancer , 1984, Cancer.

[25]  R. Herrmann,et al.  Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Ross Camidge,et al.  The European Organisation for Research and Treatment of Cancer , 2002 .